University of Iowa Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
Study for Previously Treated Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma
Description

Multicenter Phase II Study of MK-2206 in Previously Treated Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma

Participants in this research study have been diagnosed with advanced nasopharyngeal cancer. The purpose of this research study is to find out what effects, good and/or bad, an investigational drug called MK-2206 has on the participant and the nasopharyngeal cancer. Approximately 6 people will take part in this study conducted by investigators at the University of Iowa. Study involvement will last for approximately 3 years.

Start Date
October 1, 2012
End Date
June 12, 2013
Gender Preference
None
Age Group
18 - 99 years
Principal Investigator
Ahmad Wehbe, MD
Contact Info

Cindy Robertson, 319-356-2778

Department
Keywords
cancer ; head and neck ; IRB#201208779 ; metastatic nasopharyngeal carcinoma ; MK-2206 ; nasopharynx ; neoplasms ; phase 2 ; phase II ; squamous cell ; stage IV ; wehbe ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.